Pluristem Therapeutics, Inc. News Headlines

PSTI 
$2.94
*  
0.01
0.34%
Get PSTI Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading PSTI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Investing In The Stem Cell Sector: An Overview
4/17/2013 8:36:00 AM - Seeking Alpha

UTHR to Move PAH Drug into Phase I - Analyst Blog
4/15/2013 12:11:40 PM - Zacks.com

The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
4/10/2013 4:00:00 AM - Seeking Alpha

Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy
3/28/2013 9:14:00 AM - Seeking Alpha

Pipeline Progress at Pluristem - Analyst Blog
3/25/2013 6:31:03 PM - Zacks.com

The Future Of Medicine: A Look At 5 Stem Cell Companies
3/22/2013 11:58:00 AM - Seeking Alpha

Phase II Trials Will Be Pivotal For These Stem Cell Companies
3/20/2013 3:26:00 AM - Seeking Alpha

The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbert
3/15/2013 11:20:00 AM - Seeking Alpha

Pluristem & UTHR Progress with PLX-PAD - Analyst Blog
3/4/2013 6:25:01 PM - Zacks.com

2012 Stem Cell Standouts And The Outlook For 2013
2/28/2013 2:15:00 PM - Seeking Alpha

New Orphan Drug Designation For Pluristem Could Gain Access To FDA 'Progressive Approval'
2/27/2013 5:25:00 AM - Seeking Alpha

3 Regenerative Medicine Companies That Could Deliver In 2013
1/22/2013 9:33:00 AM - Seeking Alpha

Pluristem Progresses with New Facility - Analyst Blog
1/4/2013 7:27:01 PM - Zacks.com

Stem Cells, Dr. Oz And A Potentially Lucrative Investment Opportunity
1/2/2013 4:37:00 PM - Seeking Alpha

Formation Of A New Expert Group Moves Pluristem Into The Expansive Hematology Field
12/5/2012 6:59:00 PM - Seeking Alpha

Maxim Group Highlights 3 Stem Cells Stocks To Consider And 1 To Avoid
12/4/2012 10:03:00 AM - Seeking Alpha

Orphan Status Update from Pluristem - Analyst Blog
11/27/2012 7:00:01 PM - Zacks.com

4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce
11/20/2012 9:58:00 AM - Seeking Alpha

An Exciting Week In Cell Therapy
11/12/2012 3:57:00 AM - Seeking Alpha

$33,000 Portfolio: Mostly Cash Ahead Of Elections And Snow-Hurricanes
10/30/2012 10:20:00 AM - Seeking Alpha

Dilution Is The Solution To Pollution
10/9/2012 12:24:00 PM - Seeking Alpha

5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments
10/9/2012 9:45:00 AM - Seeking Alpha

Mr. Market's Stem Cell Roulette
10/5/2012 11:54:00 AM - Seeking Alpha

Tracking Recent Buy Calls And Investments By The Maxim Group
9/28/2012 8:55:00 AM - Seeking Alpha

Whatever you Do, Don't Sell This Surging Stock
9/18/2012 2:00:00 PM - David Sterman